Almac Clinical Services has increased its presence in the Asia-Pacific region by adding five new depots. The sites, located in Japan, Thailand, Hong Kong and Taiwan, enable Almac to provide customers with more flexibility in their supply chain solution for their specific country clinical trial requirements. The number of depots within the company’s global network is now 36 with another five planned for 2012.

Mark Woolf, global depot manager for Almac’s Clinical Services business unit, commented, “The latest depots are a very welcome addition to our network and have been strategically positioned in locations worldwide to ensure we can supply emerging markets with a consistent high level of service.”

Almac’s global depot network is managed by dedicated depot management teams that serve as the central contact point for the network and also perform regular visits to the depots, which are fully audited and GMP compliant. In accordance with the recent network expansion, resources within the Depot Management Team have increased over the past six months. Almac now has 15 employees located in the UK, U.S. and Brazil who are dedicated to managing protocols across the depot network. Almac is also seeking to expand its controlled drug network in Europe to ensure a network capable of storing this class of drugs within each EU country.